Webinar 'Making Sense of China's Economy' with Tao Wang, FT Best Economics Books and Chief China Economist at UBS. 🧑‍💻 Watch the replay

Kemiex joins CPhI expert panel 'China: The Future of API Production'

The CPhI Festival of Pharma welcomes specialist speakers from industry-leading pharma companies to share their insight and expertise dedicated to the new challenges that the industry is currently facing. Initially the panel discussion was planned to take place during CPhI in Milano, the world’s largest pharma convention and trade exhibition.

Time and Date: Wednesday, 7th October, 12:30h-13:30h CET

View program and register for the webinar

With 2020 being a challenging year due to the COVID-19 pandemic, the pharma industry decided to come together virtually to share its knowledge, latest developments, discoveries and cutting-edge insight.

Speakers at the CPhI Festival for Pharma event include seasoned industry experts such as Dr. Scott Gottlieb, the former 23rd commissioner of the Food and Drug Administration (FDA).

Panel discussion: China – What does the Future of API Production look like?

Over the past few years, China has emerged as one of the biggest and fastest emerging markets in the pharmaceutical and biotechnology sector worldwide. An ageing population, along with rapid economic growth, has created a tremendous window opportunity for the active pharmaceutical ingredients (APIs) industry.

With the government determined to tighten regulations governing intellectual property rights, it is expected that the market for APIs in China is going to witness a significant boost in the coming years.

Despite this, the recent COVID19 pandemic has highlighted the US and Europe’s dependence on China for consistent supplies of APIs and intermediates, with concerns on supply continuity and shortages in the spotlight, can we expect to see the West consider domestic manufacturing strategies?

About the expert panel

  • Dr. André Rieks

André is a partner and Head of Quality at Kemiex with over 20 years of experience as an international tech transfer and quality assurance manager. He is a certified Qualified Person and Third-Party Auditor according to ICH Q7 specializing in APIs, biopharmaceuticals and fine chemicals.

  • Annie Siu, PhD, MBA, Informa Intelligence and CPhI

  • Aurelio Arias, Senior Consultant Thought Leadership, IQVIA

  • Marieke van Dalen, Global Regulatory Specialist, Aspen Oss BV, and board member at APIC, the Active Pharmaceutical Ingredients Committee, a sector group of the European Chemical Industry Council (CEFIC).


Supporting links:

View all speakers

View full programme